Pay in 4 interest-free payments of $5.88 Learn more
Ships within 48 hours · Estimated delivery Aug 31 - Sep 5
Click here to find head-to-head results
10.3390/ijms21031047 41
NICE recommends semaglutide 2.4mg (Wegovy) for a maximum of 2 years on the NHS within specialist weight management services
The glucagon-like peptide (GLP)-1 agonists weight loss drugs market is on a robust growth trajectory, expected to expand from $15.5 billion in 2025 to $18.02 billion in 2026, at a CAGR of 16.3%
US$ 22.66
US$ 28.27
US$ 26.28
US$ 20.42
US$ 23.85
US$ 27.65
US$ 27.23
US$ 23.19
US$ 22.60
US$ 24.91
